Head of Investor Relations
Lifecore Biomedical, Inc. De (LFCR)Equibles does not estimate personal net worth.
Get an email with a short summary when Lifecore Biomedical, Inc. De publishes a filing, an earnings call transcript or a press release.
Get LFCR alertsStephanie Diaz is recorded as Head of Investor Relations at Lifecore Biomedical, Inc. De (LFCR). Stephanie Diaz has spoken on 7 earnings calls across 1 company, most recently for Lifecore Biomedical, Inc. De on August 5, 2026. Lifecore Biomedical, Inc. De is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Lifecore Biomedical, Inc. De includes Paul Josephs (CEO and Board Member), Craig A. Barbarosh (Chairman), Katrina L. Houde (Chairman and Board Member) and 7 others.
“Today, LifeCore Biomedical will provide its earnings results for the second quarter and six months ended June 30, 2026, and a corporate update.”
“Today, LifeCore Biomedical will provide its earnings for the first quarter ended March 31st, 2026, and corporate updates.”
“Today, LifeCore Biomedical will provide its earnings results for the fourth quarter and transition period ended December 31st, 2025, and a corporate update.”
“Good afternoon, and thank you for joining us today to discuss LifeCorp Biomedical's Fourth Quarter and Full Year Fiscal 2025 Earnings Results. Hosting the call today from Life Corps are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer.”
“Good afternoon, and thank you for joining us today to discuss Lifecore Biomedical's second quarter fiscal 2025 earnings results. Hosting the call today from Lifecore are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
